Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 50041755
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414894(CHEMBL573760)
Affinity DataIC50: 6.31nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414893(CHEMBL578426)
Affinity DataIC50: 7.94nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414892(CHEMBL576168)
Affinity DataIC50: 19.9nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414891(CHEMBL574005)
Affinity DataIC50: 31.6nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414895(CHEMBL578836)
Affinity DataIC50: 50.1nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414889(CHEMBL574443)
Affinity DataIC50: 63.1nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414890(CHEMBL565272)
Affinity DataIC50: 63.1nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414888(CHEMBL583635)
Affinity DataIC50: 79.4nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414887(CHEMBL574209)
Affinity DataIC50: 126nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414886(CHEMBL573763)
Affinity DataIC50: 200nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414885(CHEMBL574009)
Affinity DataIC50: 251nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414884(CHEMBL573770)
Affinity DataIC50: 251nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414883(CHEMBL576948)
Affinity DataIC50: 316nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414881(CHEMBL575913)
Affinity DataIC50: 501nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414882(CHEMBL582642)
Affinity DataIC50: 501nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414880(CHEMBL574208)
Affinity DataIC50: 631nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414878(CHEMBL575914)
Affinity DataIC50: 794nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414879(CHEMBL573280)
Affinity DataIC50: 794nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414877(CHEMBL574006)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414876(CHEMBL575078)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414875(CHEMBL575915)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414874(CHEMBL583189)
Affinity DataIC50: 1.58E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414873(CHEMBL578663)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414872(CHEMBL574010)
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414871(CHEMBL577153)
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414869(CHEMBL566755)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414870(CHEMBL566756)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetEukaryotic translation initiation factor 2-alpha kinase 1(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50414868(CHEMBL574630)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HRI kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed